ANGLE Plc (AGL):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:ANGLE Plc (AGL) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6633
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ANGLE Plc (ANGLE) is a medical diagnostic company that offers cancer diagnostics and foetal health products. The company develops products for use in rare cell diagnostics that enable early, accurate identification of an individual’s condition for the prevention, treatment, and monitoring of disease. Its product Parsortix cell separation system, which captures very rare circulating tumor cells in cancer patient blood. ANGLE’s Parsortix cell separation system uses a microfluidic technology in the form of a one-time use cassette to capture and then harvest circulating tumor cells (CTCs) from blood. The company’s cassette captures CTCs based on their less deformable nature and larger size compared to other blood components. It provides liquid biopsy (blood test) that enables the detection and investigation of mutations in the patient’s cancer for personalized cancer care. The company’s harvested CTCs have a range of applications such as diagnosis, prognosis, mutational analysis and drug selection, drug development, assessment of treatment effectiveness and remission monitoring. It has operations in the US and the UK. ANGLE is headquartered in Guildford, the UK.

ANGLE Plc (AGL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ANGLE Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ANGLE Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ANGLE Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ANGLE Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
ANGLE Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
ANGLE Plc, Medical Equipment, Deal Details 10
Asset Purchase 10
ANGLE Acquires Assets from Axela 10
Private Equity 11
ANGLE Raises USD2.5 Million in Private Placement of Shares 11
Partnerships 12
ANGLE Enters into Option Agremeent with Queen Mary University of London 12
ANGLE Enters into Co-Marketing Agreement with Qiagen 13
Angle Enters into Agreement with MD Anderson Cancer Center 14
EKF Diagnostics Enters into Co-Development Agreement with Angle 15
ANGLE Enters Into Co-Development Agreement With Paterson Institute for Cancer Research 16
Equity Offering 17
Angle Raises USD16.8 Million in Private Placement of Shares 17
ANGLE Raises USD3.7 Million in Private Placement of Shares 19
ANGLE Raises USD13.7 Million in Private Placement of Shares 20
ANGLE to Raise USD14.8 Million in Private Placement of Shares 21
Angle to Raise USD2.3 Million in Rights Offering of Shares 22
Angle to Raise USD11.17 Million in Private Placement of Shares 23
Angle Completes Private Placement Of Shares For US$3.5 Million 24
ANGLE Completes Private Placement Of Shares For US$1.9 Million 25
ANGLE Plc – Key Competitors 26
ANGLE Plc – Key Employees 27
ANGLE Plc – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Financial Announcements 29
Jul 25, 2018: ANGLE: Preliminary Results for the year ended 30 April 2018 29
Jan 31, 2018: ANGLE: Interim Results for the six months ended 31 October 2017 33
Jul 27, 2017: ANGLE: Preliminary Results for the year ended 30 April 2017 35
Jan 26, 2017: Angle: Interim Results for the six months ended 31 October 2016 40
Corporate Communications 41
May 14, 2018: Angle Appoints Leading NHS Prostate Cancer Surgeon As Scientific Advisor 41
Product News 42
Jan 26, 2017: ANGLE: Positive Interim Evaluation of Ovarian Cancer Clinical Studies 42
Other Significant Developments 43
May 03, 2017: ANGLE: Business Update Highlights Progress With Parsortix Liquid Biopsy 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
ANGLE Plc, Medical Equipment, Key Facts, 2018 2
ANGLE Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
ANGLE Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ANGLE Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ANGLE Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ANGLE Plc, Deals By Market, 2012 to YTD 2018 8
ANGLE Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
ANGLE Acquires Assets from Axela 10
ANGLE Raises USD2.5 Million in Private Placement of Shares 11
ANGLE Enters into Option Agremeent with Queen Mary University of London 12
ANGLE Enters into Co-Marketing Agreement with Qiagen 13
Angle Enters into Agreement with MD Anderson Cancer Center 14
EKF Diagnostics Enters into Co-Development Agreement with Angle 15
ANGLE Enters Into Co-Development Agreement With Paterson Institute for Cancer Research 16
Angle Raises USD16.8 Million in Private Placement of Shares 17
ANGLE Raises USD3.7 Million in Private Placement of Shares 19
ANGLE Raises USD13.7 Million in Private Placement of Shares 20
ANGLE to Raise USD14.8 Million in Private Placement of Shares 21
Angle to Raise USD2.3 Million in Rights Offering of Shares 22
Angle to Raise USD11.17 Million in Private Placement of Shares 23
Angle Completes Private Placement Of Shares For US$3.5 Million 24
ANGLE Completes Private Placement Of Shares For US$1.9 Million 25
ANGLE Plc, Key Competitors 26
ANGLE Plc, Key Employees 27
ANGLE Plc, Other Locations 28

List of Figures
ANGLE Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
ANGLE Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
ANGLE Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
ANGLE Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
ANGLE Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ANGLE Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
ANGLE Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ANGLE Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[ANGLE Plc (AGL):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Moberg Pharma AB (MOB):企業の財務・戦略的SWOT分析
    Summary Moberg Pharma AB (Moberg Pharma), formerly Moberg Derma AB, is a pharmaceutical company. The company provides commercializes proprietary, acquired and licensed products. It provides treatment of skin diseases. Moberg Pharma treats fungal infection or psoriasis, discolored and fungus-damaged …
  • Electrical Geodesics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Electrical Geodesics Inc (EGI) is a medical device company that designs, develops and commercializes non-invasive neuro diagnostic products used to monitor and interpret brain activity. The company offers clinical products such as geodesic EEG system 400 series, spike detection software, geo …
  • Net One Systems Co Ltd (7518):企業の財務・戦略的SWOT分析
    Net One Systems Co Ltd (7518) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Ngai Hing Hong Co Ltd (1047):企業の財務・戦略的SWOT分析
    Ngai Hing Hong Co Ltd (1047) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Baloise Holding Ltd (BALN):企業の財務・戦略的SWOT分析
    Baloise Holding Ltd (BALN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196):企業の財務・戦略的SWOT分析
    Summary Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company’s pharmaceutical products include metabolism …
  • Sangam (India) Ltd.:企業の戦略・SWOT・財務分析
    Sangam (India) Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sangam (India) Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Nichii Gakkan Co Ltd (9792):企業の財務・戦略的SWOT分析
    Nichii Gakkan Co Ltd (9792) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Compagnie Financiere Richemont SA:戦略・SWOT・企業財務分析
    Compagnie Financiere Richemont SA - Strategy, SWOT and Corporate Finance Report Summary Compagnie Financiere Richemont SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Nanobiotix SA (NANO):企業の製品パイプライン分析
    Summary Nanobiotix SA (Nanobiotix) designs and manufactures nanomedicines for the treatment of cancer. The company is evaluating its lead product candidate NBTXR3 against soft tissue sarcoma, pancreatic, liver, rectal, prostate, head and neck cancers; Non-small cell lung cancer (NSCLC); recurrent he …
  • Isagen SA ESP-エネルギー分野:企業M&A・提携分析
    Summary Isagen SA ESP (Isagen), a subsidiary of Brookfield Renewable Energy Partners LP, is an electricity utility. It generates and markets electricity; supplies natural gas; and sells coal, steam, and other energy sources. The company produces electric energy from hydro and natural gas sources. Is …
  • Lamprell Plc (LAM):石油・ガス:M&Aディール及び事業提携情報
    Summary Lamprell Plc (Lamprell) is an oil and gas company that provides offshore industry services. The company's business activities comprise construction of new build jackup drilling rigs, construction projects for the offshore oil and gas industry, engineering and construction, renewable and mult …
  • Boiron SA:企業の戦略・SWOT・財務分析
    Boiron SA - Strategy, SWOT and Corporate Finance Report Summary Boiron SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Polyganics BV:製品パイプライン分析
    Summary Polyganics BV (Polyganics) is a medical technology company, which develops, manufactures and commercializes bioresorbable medical devices that facilitate tissue repair and regeneration. Polyganics offers a range of products for ear, nose and throat (ENT) procedures; peripheral nerve repair ( …
  • CommScope Holding Company Inc:企業のM&A・事業提携・投資動向
    CommScope Holding Company Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CommScope Holding Company Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Imagination Technologies Group plc:企業のM&A・事業提携・投資動向
    Imagination Technologies Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Imagination Technologies Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • Yakult Honsha Co Ltd (2267):企業の財務・戦略的SWOT分析
    Yakult Honsha Co Ltd (2267) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Itamar Medical Ltd (ITMR):企業の財務・戦略的SWOT分析
    Summary Itamar Medical Ltd (Itamar Medical) is a medical device company that develops, manufactures, and markets non-invasive medical devices for the diagnosis of cardiology disease and sleep related breathing disorders. It develops products using its proprietary peripheral arterial tonometry (PAT) …
  • Islandsbanki hf.:企業の戦略・SWOT・財務分析
    Islandsbanki hf. - Strategy, SWOT and Corporate Finance Report Summary Islandsbanki hf. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Veloxis Pharmaceuticals AS (VELO)-製薬・医療分野:企業M&A・提携分析
    Summary Veloxis Pharmaceuticals A/S (Veloxis) is a specialty pharmaceutical company, which develops therapies for kidney transplantation based on its proprietary MeltDose platform. MeltDose is a drug delivery technology, used to enhance oral bioavailability and control release of a drug. The company …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆